Clinical Trials Browser

Terminated × Breast Neoplasms × inavolisib × Clear all

NCT04849364 2025-05-31

PERSEVERE

Phase 2 Terminated

52 enrolled 16 charts

Breast Neoplasms, Triple Negative Breast Neoplasms